Analysts think SPRO stock price could increase by 80%
Dec 06, 2025, 12:25 PM
2.64%
What does SPRO do
Spero Therapeutics, based in Cambridge, Massachusetts, develops treatments for multi-drug resistant infections and rare diseases, with key products including SPR720, tebipenem HBr, and SPR206. The company went public on November 2, 2017, and employs 46 people.
3 analysts think SPRO stock price will increase by 79.74%. The current median analyst target is $4.08 compared to a current stock price of $2.27. The lowest analysts target is $4.04 and the highest analyst target is $4.20.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.